# The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure

> **NCT04688294** · PHASE4 · COMPLETED · sponsor: **Amir Safwat** · enrollment: 60 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Sacubitril-Valsartan
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT04688294
- **Lead sponsor:** Amir Safwat
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04688294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04688294, "The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04688294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*